A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer

This study is ongoing, but not recruiting participants.

Sponsor:

ClinicalTrials.gov Identifier:

NCT01101438

First Posted: April 12, 2010

Last Update Posted: March 24, 2017

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

Collaborators:

National Cancer Institute (NCI)

International Breast Cancer Study Group

ICR-CTSU

Information provided by (Responsible Party):

Canadian Cancer Trials Group

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	July 2020
Estimated Primary Completion Date:	January 2020 (Final data collection date for primary outcome measure)

Study Status:

This study is ongoing, but not recruiting participants.

Estimated Study Completion Date:

July 2020

Estimated Primary Completion Date:

January 2020 (Final data collection date for primary outcome measure)